Iterum Therapeutics launches rights offering of up to $10.3M in Units at $1.21/unit

Iterum Therapeutics plc

Maximum 8,503,800 Units offered at $1.21/unit; each Unit includes one ordinary share, a 0.5-share 1-year warrant, and a 1-share 5-year warrant.
Subscription period July 22 to August 6, 2024; rights are non-transferable; proceeds if fully subscribed ~$10.3M.
Record date July 16, 2024; each shareholder/warrant holder receives one right per share/warrant to purchase 0.5 Units.
One eligible warrant holder waived participation; Maxim Group LLC is dealer-manager.
Rights offering previously disclosed; registration statement declared effective by SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.